A Case of Blau Syndrome with NOD2 E383K Mutation

被引:12
|
作者
Harada, Jun [1 ]
Nakajima, Takeshi [1 ]
Kanazawa, Nobuo [2 ]
机构
[1] Osaka Gen Med Ctr Med, Dept Dermatol, Osaka, Japan
[2] Wakayama Med Univ, Dept Dermatol, Wakayama, Japan
关键词
TRANSIENT PORPHYRINEMIA; PHOTOTHERAPY; ERUPTION; PHOTOSENSITIVITY; PATHOGENESIS; NEONATE;
D O I
10.1111/pde.12908
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
uWe report a 3.5-year-old Japanese boy who developed lichenoid papules and erythema with noncaseating epithelioid cell granulomas with a scant lymphocytic infiltrate histologically on his limbs at the age of 8 months. Genetic analysis of the patient and his parents, who had no medical past history, revealed heterozygous 1147G>A ( E383K) mutation of NOD2 in the patient and in his father, so the patient was diagnosed with Blau syndrome and his father as an asymptomatic carrier. Although Blau syndrome has been reported as a genetic disease with high penetrance, asymptomatic carrier cases of a family with the same E383K mutation have also been reported. These results suggest that some contributing factors are required for the development of inflammatory and granulomatous responses in heterozygous carriers of a NOD2 E383K mutation.
引用
收藏
页码:E385 / E387
页数:3
相关论文
共 50 条
  • [21] Blau Arteritis Resembling Takayasu Disease with a Novel NOD2 Mutation
    Khubchandani, Raju P.
    Hasija, Rachana
    Touitou, Isabelle
    Khemani, Chetna
    Wouters, Carine H.
    Rose, Carlos D.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (09) : 1888 - 1892
  • [22] A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members
    Milman, N.
    Ursin, K.
    Rodevand, E.
    Nielsen, F. C.
    Hansen, T. V. O.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (03) : 190 - 197
  • [23] Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene
    Raiji, Veena Rao
    Miller, Marijean M.
    Jung, L. K.
    JOURNAL OF AAPOS, 2011, 15 (02): : 205 - 207
  • [24] Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis
    Rosé, CD
    Doyle, TM
    McIlvain-Simpson, G
    Coffman, JE
    Rosenbaum, JT
    Davey, MP
    Martin, TM
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (02) : 373 - 375
  • [25] A Novel Pathogenic NOD2 Variant in a Mother and Daughter with Blau Syndrome
    Rodrigues, Filipa G.
    Petrushkin, Harry
    Webster, Andrew R.
    Bickerstaff, Maria
    Moraitis, Elena
    Rowczenio, Dorota
    Arostegui, Juan, I
    Westcott, Mark
    OPHTHALMIC GENETICS, 2021, 42 (06) : 753 - 764
  • [26] Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
    Ueki, Yoko
    Takimoto-Ito, Riko
    Saito, Megumu K. K.
    Tanizaki, Hideaki
    Kambe, Naotomo
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?
    Inoue, Yuzaburo
    Kawaguchi, Yasushi
    Shimojo, Naoki
    Yamaguchi, Kenichi
    Morita, Yoshinori
    Nakano, Taiji
    Arima, Takayasu
    Tomiita, Minako
    Kohno, Yoichi
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 837 - 839
  • [28] Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation
    Matsuda, Tomoko
    Kambe, Naotomo
    Ueki, Yoko
    Kanazawa, Nobuo
    Izawa, Kazushi
    Honda, Yoshitaka
    Kawakami, Atsushi
    Takei, Syuji
    Tonomura, Kyoko
    Inoue, Masami
    Kobayashi, Hiroko
    Okafuji, Ikuo
    Sakurai, Yoshihiko
    Kato, Naoki
    Maruyama, Yuta
    Inoue, Yuzaburo
    Otsubo, Yoshikazu
    Makino, Teruhiko
    Okada, Satoshi
    Kobayashi, Ichiro
    Yashiro, Masato
    Ito, Shusaku
    Fujii, Hiroshi
    Kondo, Yasuhiro
    Okamoto, Nami
    Ito, Shuichi
    Iwata, Naomi
    Kaneko, Utako
    Doi, Mototsugu
    Hosokawa, Junichi
    Ohara, Osamu
    Saito, Megumu K.
    Nishikomori, Ryuta
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (11) : 1492 - 1499
  • [29] Blau Syndrome-Associated Nod2 Mutation Alters Expression of Full-Length NOD2 and Limits Responses to Muramyl Dipeptide in Knock-in Mice
    Dugan, Jae
    Griffiths, Eric
    Snow, Paige
    Rosenzweig, Holly
    Lee, Ellen
    Brown, Brieanna
    Carr, Daniel W.
    Rose, Carlos
    Rosenbaum, James
    Davey, Michael P.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (01): : 349 - 357
  • [30] Role of NOD2 Pathway in Sarcoidosis Cases with Characteristics of Blau Syndrome.
    Dumancas, Gerard
    Adrianto, Indra
    Levin, Albert M.
    Iannuzzi, Michael C.
    Rybicki, Benjamin A.
    Montgomery, Courtney
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S498 - S498